Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free TRDA Stock Alerts

Entrada Therapeutics (TRDA) Insider Trading & Ownership

Entrada Therapeutics logo
$7.02 +0.20 (+2.86%)
As of 02:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Entrada Therapeutics (NASDAQ:TRDA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.49%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$1.38M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$6.56M
Get TRDA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRDA Insider Buying and Selling by Quarter

Entrada Therapeutics Insider and Congressional Trades History

Export
Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/20/2026
Bernhardt G Zeiher
Director
Buy5,000$5.86$29,300.00  
5/4/2026
Natarajan Sethuraman
Natarajan Sethuraman
Insider
Sell25,907$15.39$398,708.73  
5/4/2026
Nathan J Dowden
Nathan J Dowden
COO
Sell15,000$15.33$229,950.00  
4/1/2026
Kory James Wentworth
Kory James Wentworth
CFO
Sell2,500$12.95$32,375.00  
3/10/2026
Kory James Wentworth
Kory James Wentworth
CFO
Sell11,388$13.02$148,271.76  
3/10/2026
Nathan J Dowden
Nathan J Dowden
COO
Sell11,894$13.05$155,216.70  
3/9/2026
Kory James Wentworth
Kory James Wentworth
CFO
Sell5,089$13.00$66,157.00  
3/9/2026
Nathan J Dowden
Nathan J Dowden
COO
Sell3,116$13.02$40,570.32  
3/4/2026
Kory James Wentworth
Kory James Wentworth
CFO
Sell7,988$12.25$97,853.00  
11/21/2025
Kory James Wentworth
Kory James Wentworth
CFO
Sell8,910$9.98$88,921.80  
11/14/2025
Kush Parmar
Kush Parmar
Director
Sell200,000$8.80$1,760,000.00  
11/14/2025
Ventures V L.P. 5Am
Major Shareholder
Sell200,000$8.80$1,760,000.00  
11/12/2025
Bros. Advisors Lp Baker
Major Shareholder
Buy100,736$7.76$781,711.36  
11/11/2025
Bros. Advisors Lp Baker
Major Shareholder
Buy46,434$7.50$348,255.00  
11/10/2025
Bros. Advisors Lp Baker
Major Shareholder
Buy30,874$7.21$222,601.54  
7/9/2025
Kush Parmar
Kush Parmar
Director
Sell27,000$7.50$202,500.00  
7/9/2025
Ventures V L.P. 5Am
Major Shareholder
Sell20,065$7.50$150,487.50  
7/9/2025
Ventures V L.P. 5Am
Major Shareholder
Sell6,935$7.50$52,012.50  
6/30/2025
Kush Parmar
Kush Parmar
Director
Sell25,000$6.81$170,250.00  
6/30/2025
Ventures V L.P. 5Am
Major Shareholder
Sell18,578$6.81$126,516.18  
6/30/2025
Ventures V L.P. 5Am
Major Shareholder
Sell6,422$6.81$43,733.82  
6/27/2025
Kush Parmar
Kush Parmar
Director
Sell75,000$6.91$518,250.00  
6/27/2025
Ventures V L.P. 5Am
Major Shareholder
Sell55,735$6.91$385,128.85  
6/27/2025
Ventures V L.P. 5Am
Major Shareholder
Sell19,265$6.91$133,121.15  
(Data available from 1/1/2013 forward)

TRDA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Entrada Therapeutics includes Bernhardt G Zeiher, Bioventures 2018 L.P. Mpm, Bros. Advisors Lp Baker, Dipal Doshi, Kory James Wentworth, Kush Parmar, Natarajan Sethuraman, Nathan J Dowden, Nerissa Kreher, Peter S Kim, and Ventures V L.P. 5Am. Learn more on insiders at TRDA.

9.49% of Entrada Therapeutics stock is owned by insiders. Learn more on TRDA's insider holdings.

The following insiders have purchased TRDA shares in the last 24 months: Bernhardt G Zeiher ($29,300.00), and Bros. Advisors Lp Baker ($1,352,567.90).

Insiders have purchased a total of 183,044 TRDA shares in the last 24 months for a total of $1,381,867.90 bought.

The following insiders have sold TRDA shares in the last 24 months: Bioventures 2018 L.P. Mpm ($476,359.95), Dipal Doshi ($50,066.00), Kory James Wentworth ($800,227.07), Kush Parmar ($2,651,000.00), Natarajan Sethuraman ($563,106.60), Nathan J Dowden ($474,043.11), and Ventures V L.P. 5Am ($2,651,000.00).

Insiders have sold a total of 803,556 Entrada Therapeutics shares in the last 24 months for a total of $7,665,802.73 sold.

Entrada Therapeutics Active Insiders


Related Companies
Insider Tracking Tools
Insider Trading By Country

This page (NASDAQ:TRDA) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel